These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 27111134)

  • 41. Bipolar disorder: historic perspective, current pharmacologic treatment options and a review of quetiapine.
    Khouzam HR; Singh F
    Expert Rev Neurother; 2006 Feb; 6(2):131-44. PubMed ID: 16466293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bipolar disorder: current clinical research trends.
    Gitlin M
    Expert Rev Neurother; 2005 Jan; 5(1):1-4. PubMed ID: 15853467
    [No Abstract]   [Full Text] [Related]  

  • 43. Unmet clinical needs in bipolar disorder.
    Sachs GS
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S2-8. PubMed ID: 12832943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antidepressants in bipolar disorder].
    Courtet P; Samalin L; Olié E
    Encephale; 2011 Dec; 37 Suppl 3():S196-202. PubMed ID: 22212875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.
    Möller HJ; Grunze H; Broich K
    Eur Arch Psychiatry Clin Neurosci; 2006 Feb; 256(1):1-16. PubMed ID: 16078087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bipolar disorder.
    Mitchell PB
    Aust Fam Physician; 2013 Sep; 42(9):616-9. PubMed ID: 24024220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bipolar (spectrum) disorder and mood stabilization: standing at the crossroads?
    De Fruyt J; Demyttenaere K
    Psychother Psychosom; 2007; 76(2):77-88. PubMed ID: 17230048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part III. The alternatives!].
    Hausmann A; Fuchs M; Walpoth M; Hörtnagl C; Adami P; Conca A
    Neuropsychiatr; 2007; 21(4):248-60. PubMed ID: 18082106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bipolar II disorder: arguments for and against a distinct diagnostic entity.
    Vieta E; Suppes T
    Bipolar Disord; 2008 Feb; 10(1 Pt 2):163-78. PubMed ID: 18199235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bipolar Disorder.
    Miller TH
    Prim Care; 2016 Jun; 43(2):269-84. PubMed ID: 27262007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prescribing patterns of antidepressants, antipsychotics and mood stabilizers in bipolar patients misdiagnosed with major depressive disorder in China.
    Xiang YT; Hu C; Wang G; Zheng QW; Fang YR; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Chen DF; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
    Hum Psychopharmacol; 2012 Nov; 27(6):626-31. PubMed ID: 23027671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lithium combinations in acute and maintenance treatment of unipolar and bipolar depression.
    Fawcett JA
    J Clin Psychiatry; 2003; 64 Suppl 5():32-7. PubMed ID: 12720482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Twenty years of Lithium pharmacogenetics: A systematic review.
    Pagani R; Gasparini A; Ielmini M; Caselli I; Poloni N; Ferrari M; Marino F; Callegari C
    Psychiatry Res; 2019 Aug; 278():42-50. PubMed ID: 31146140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bipolar disorder: advances in the prediction of lithium response and development of new therapies using induced pluripotent stem cells].
    Santos R; Charnay P
    Med Sci (Paris); 2017 Dec; 33(12):1048-1050. PubMed ID: 29261491
    [No Abstract]   [Full Text] [Related]  

  • 57. Neuropsychiatric disorders: Shared genetics of bipolar disorder and schizophrenia.
    Potash JB; Bienvenu OJ
    Nat Rev Neurol; 2009 Jun; 5(6):299-300. PubMed ID: 19498428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment-resistant mood disorders].
    Machado-Vieira R; Soares JC
    Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S48-54. PubMed ID: 17713691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Schizophrenia and bipolar affective disorder: perspectives for the development of therapeutics.
    Sundram S; Joyce PR; Kennedy MA
    Curr Mol Med; 2003 Aug; 3(5):393-407. PubMed ID: 12942993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What constitutes evidence-based pharmacotherapy for bipolar disorder? Part 1: first-line treatments.
    Goldberg JF
    J Clin Psychiatry; 2007 Dec; 68(12):1982-3. PubMed ID: 18162032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.